A widely practicable treatment that reduces blood loss after trauma could prevent thousands of premature deaths each year. The CRASH-2 trial aimed to determine the effect of the early administration of tranexamic acid on death and transfusion requirement in …

Randomised using 24hr free call service balanced by centre, with an allocation sequence based on a block size of eight. If no telephone is available, taking the next consecutive randomisation pack. TXA safely reduced the risk of death in bleeding trauma patients in this study.

2010年7月3日 · CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage 2) is a large placebo-controlled trial of the effects of early administration of a short course of tranexamic acid on death, vascular occlusive events, and the receipt of …

Crash Bandicoot 2: Cortex Strikes Back is a 1997 platform game developed by Naughty Dog and published by Sony Computer Entertainment for the PlayStation. It is a sequel to Crash Bandicoot (1996), and is part of the Crash Bandicoot series.

As the title suggests, this is a full 100% walkthrough of Crash Bandicoot 2. I play through the entire game from start to finish, and I collect every single gem and crystal on the way.

1997年11月5日 · Release Date, Trailers, News, Reviews, Guides, Gameplay and more for Crash Bandicoot 2: Cortex Strikes Back

Crash Bandicoot 2: Cortex Strikes Back: Directed by Andrew S. Gavin, Jason Rubin. With Clancy Brown, Brendan O'Brien, Vicki Winters, Haruna Ikezawa. Crash Bandicoot is on an adventure to collect crystals and help Dr. Neo Cortex save the world, or so it seems.

Now you can experience Crash Bandicoot like never before in fully-remastered HD graphical glory. Take on the epic challenges and adventures of the three games that started it all, Crash Bandicoot®, Crash Bandicoot® 2: Cortex Strikes Back and Crash Bandicoot®: Warped.

The CRASH-2 (Clinical Randomisation of an Antifibrinolytic in Significant Haemorrhage) trial, conducted in 20,211 bleeding trauma patients evaluated the effect on mortality and transfusion requirements of TXA in trauma patients with significant bleeding.

CRASH 2 is a large pragmatic randomised placebo controlled trial of the effects of the early administration of the antifibrinolytic agent tranexamic acid on death, vascular events and transfusion requirements.